Eevia Health Plc received an increase of 115 kSEK / 11 kEUR to an earlier sales order for a Bilberry extract worth 228 SEK / 21 kEUR

Eevia Health Plc's ("Eevia" or "The Company") has received an extension of 11 kEUR (115 kSEK) to the sales order of 22 kEUR (228 kSEK) which was press released by Eevia on December 20th 2023. The order and extra-order is from a German customer for Feno-Myrtillus 36 organic, an organically certified bilberry extract.

Eevia received an increase to a sales order a German customer made on December 20th, 2023. The sales value to Eevia of this additional order is c. kEUR 11 EUR, so the total sales order is now kEUR 33. Eevia has the product in stock for immediate delivery. The product is Eevia's branded ingredient Feno-Myrtillus® 36 Organic.

The order is expected to be followed by further repeat orders in the future.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]  or [email protected]       

Telephone: +358 400 22 5967   


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]